SOLENO THERAPEUTICS INC - 10-Q Filing
Solenos Therapeutics filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes details on financial instruments such as operating lease liabilities, fair value measurements of corporate debt and commercial paper securities, stock options under equity incentive plans, retained earnings, and accumulated other comprehensive income.
Tickers: $SLNO